Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 11/20 | 0.41 |
| ▸ | CTSS | P25774 | 5/20 | 0.40 |
| ▸ | REN | P00797 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CTSL | P07711 | 4/20 | 0.39 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.38 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.38 |
| ▸ | CASP1 | P29466 | 1/20 | 0.38 |
| ▸ | ITGAV | P06756 | 1/20 | 0.38 |
| ▸ | CTSB | P07858 | 1/20 | 0.38 |
| ▸ | PREP | P48147 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6981067 | 0.88 | CTSK (0.46) | CTSKCTSSCTSLCTSB | |
| SCHEMBL6983831 | 0.81 | CTSK (0.44) | CTSKCTSSCTSLCTSB | |
| SCHEMBL6986934 | 0.81 | CTSK (0.44) | CTSKCTSSCTSLCTSB | |
| SCHEMBL6986438 | 0.80 | CTSK (0.45) | CTSKCTSSCTSLCTSB | |
| SCHEMBL6983113 | 0.72 | CYP1A2 (0.36) | CTSKCTSSRENCYP1A2CTSL | |
| SCHEMBL6986262 | 0.71 | CTSK (0.44) | CTSKCTSSCTSLCTSB | |
| SCHEMBL6982381 | 0.71 | CTSK (0.43) | CTSKCTSSRENCYP1A2CTSL | |
| SCHEMBL6985021 | 0.70 | CTSK (0.45) | CTSKCTSSCTSLCTSB | |
| SCHEMBL25247153 | 0.68 | CTSK (0.63) | CTSKCTSSRENCTSLCASP1 | |
| SCHEMBL25286871 | 0.68 | CTSK (0.63) | CTSKCTSSRENCTSLCASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1089964-B1 | HYDRAZINE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2003-10-29 | — | — | EP | disclosed |
| US-6239151-B1 | TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES, OSTEOARTHRITIS, RESPIRATORY DISEASES, TUMORS, CACHEXIA, CARDIOVASCULAR DISEASES, FEVER, HAEMORRHAGE AND SEPSIS, HYDRAZINE DERIVATIVES, | HOFFMANN-LA ROCHE INC. | 2001-05-29 | — | — | US | disclosed |
| EP-1089964-A1 | HYDRAZINE DERIVATIVES | F.HOFFMANN-LA ROCHE AG (CH) | 2001-04-11 | — | — | EP | disclosed |
| WO-2000000465-A1 | HYDRAZINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2000-01-06 | — | — | WO | disclosed |